Skip to main content

Advertisement

Table 3 Ongoing pharmacological treatment in studied groups

From: No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea

Pharmacological treatment Number of patients receiving treatment
  OSAS, n = 27 CPAP-OSAS, n = 22 Controls, n = 11
ACEI 12 10 2
Diuretics 11 6 1
Ca2+ channel blocker 4 5 1
Beta-blockers 4 1 1
Nitrates 4 4 1
Digitalis 3 1 0
Statins 8 6 0
Allopurinol 0 4 0
Ticlopidine 2 0 1
Gliclazide 1 5 0
  1. ACEI – angiotensin converting enzyme inhibitors; OSAS – patients with untreated OSAS; CPAP-OSAS – patients with OSAS treated successfully after a first attempt with CPAP, controls – subjects without OSAS. Four, 2, and 6 subjects were free of any medication in OSAS, CPAP-OSAS and controls group, respectively.